Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
NCT ID: NCT01546376
Last Updated: 2012-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection
NCT01296373
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
NCT01245101
Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
NCT01844310
Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression
NCT03251690
Raltegravir Therapy for Women With HIV and Fat Accumulation
NCT00656175
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV-cancer patients who recived RT
Radiation therapy
External photon beam radiation therapy dosage 4000-7000 CGy
Venepuncture
Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiation therapy
External photon beam radiation therapy dosage 4000-7000 CGy
Venepuncture
Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV positive cancer patients
* Photon beam RT, conventional fraction \>= 4000 cgy in 4 weeks
Exclusion Criteria
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Department of Medical Services Ministry of Public Health of Thailand
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rajavithi Hospital
Bangkok, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THAIHIV001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.